Prolactin regulation of testosterone secretion and testes growth in DLS rams at the onset of seasonal testicular recrudescence.
Our objective was to test the hypothesis that prolactin (PRL) acts at both the pituitary and testis levels to regulate testosterone secretion in the adult ram. The focus was on the mid-regression to mid-redevelopment stages of a photoperiod-condensed 'seasonal' testicular cycle. DLS rams (six per group) were given daily s.c. injections of bromocriptine (4 mg) or vehicle during the entire period. Serum PRL concentration in control rams peaked at 103.4+/-22.1 ng/ml in late regression and then steadily declined (P<0.01) to 19.5+/-4.3 ng/ml, whereas PRL in treated rams was always < or =4.0 ng/ml. Suppression of PRL tended (P<0.10) to increase the amplitude of natural LH pulses (transition stages) or reduce the number of LH receptors in the testis (regressed stage), although neither change disturbed testosterone levels in peripheral blood. These subtle changes were accompanied by significant (P<0.05) alterations in the capability of the pituitary to release LH (85% more) and of the testes to secrete testosterone (20% less). These effects of PRL were unmasked when rams were given highly stimulative i.v. injections of GNRH (single 3 microg dose) and NIH-oLH-S24 (three 5 microg doses given 20 min apart) respectively. PRL insufficiency also appeared to slow down the 'seasonal' rise in FSH secretion and slightly delayed (2 weeks) the times when the testes began to grow and were first significantly (P<0.05) enlarged from the regressed state. We conclude that PRL is an important part of the intricate regulation of the pituitary-gonadal system in moderately seasonal DLS rams.
Sanford
L M
LM
Department of Animal Science, McGill University, Macdonald Campus, Ste Anne de Bellevue, Québec, Canada. lsanford@total.net
Baker
S J
SJ
D000222:Adaptation, Physiological; D000818:Animals; D015415:Biomarkers; D001971:Bromocriptine / Q000494:pharmacology*; D005640:Follicle Stimulating Hormone / Q000097:blood / Q000378:metabolism; D007987:Gonadotropin-Releasing Hormone / Q000494:pharmacology; D006727:Hormone Antagonists / Q000494:pharmacology*; D007985:Leydig Cells / Q000502:physiology; D007986:Luteinizing Hormone / Q000097:blood / Q000378:metabolism / Q000494:pharmacology; D008297:Male; D009929:Organ Size; D017440:Photoperiod; D010902:Pituitary Gland / Q000378:metabolism; D011388:Prolactin / Q000037:antagonists & inhibitors / Q000097:blood / Q000502:physiology*; D012008:Recurrence; D012611:Scrotum / Q000033:anatomy & histology; D012621:Seasons; D012636:Secretory Rate; D012708:Sertoli Cells / Q000502:physiology; D034561:Sheep, Domestic; D013737:Testis / Q000033:anatomy & histology / Q000378:metabolism / Q000502:physiology*; D013739:Testosterone / Q000097:blood / Q000378:metabolism*; D013997:Time Factors
D015415:Biomarkers; D006727:Hormone Antagonists; D007987:Gonadotropin-Releasing Hormone; D001971:Bromocriptine; D013739:Testosterone; D011388:Prolactin; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone